VTAK logo

CATHETER PRECISION INC

VTAKNYSE AMERICAN
🏆 #5487 by market capUS Equity
$0.15▼ $0.00 (−3.22%)
Live
🔔
Track VTAK
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 3.2%
7d▼ 1.3%
14d▼ 12.6%
30d▼ 25.7%
ytd▼ 91.2%
1y▼ 94.1%
🏦Market Cap
$404,679
Small Cap
📈Revenue Growth (YoY)
+95.0%
High Growth
📊Gross Margin
47.7%
Healthy
💵FCF Margin
-491.8%
Thin
⚖️P/S Ratio
0.2x
Cheap
Otter Score
28
Weak

Trading Snapshot

Day Range
$0.15 – $0.15
52-Week Range
$0.13 – $3.20
Volume
$3.62B
Avg Volume
$3.66B
Shares Outstanding
2.7M
Next Earnings
Dec 7, 2026

Fundamentals Snapshot

Annual Revenue
$819,000
Last Q Revenue
$1M
P/E Ratio
-0.0
P/S Ratio
0.2x
EPS (TTM)
$-0.00
Dividend Yield
0.00%
Dilution (1yr)
+13399.9%

Why Investors Own VTAK

  • ✓High-growth profile — revenue up -9.6% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 26% gross margin and 30% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

VTAK logo

CATHETER PRECISION INC

VTAK
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$819K▲ +95.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
92.3%▲ +2.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$12M▲ +8.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$8M▼ −11.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.08B▲ +13399.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$4M▼ −$5M YoY
StockOtter · stockotter.space

About CATHETER PRECISION INC

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
28/100

Analyst Price Target

ⓘ
Average Target
$0.16
▲ +4.6% Upside
High Target$0.18
Low Target$0.14
Based on 38 analysts

Latest News & Updates

🚀
Reuters·2h ago

CATHETER PRECISION INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Reuters·5h ago

Analysts lift VTAK price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

CATHETER PRECISION INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.